News
Stay up to date on the latest company news:
4 November 2025
Abalos Therapeutics to Present Preclinical Data Highlighting Potent, Synergistic Effects of ABX-001 in Combination with Bispecific T-cell Engagers at SITC 2025
23 October 2025
Abalos Therapeutics Doses First Patient in Phase 1 Study Evaluating ABX-001 for the Treatment of Solid Tumors
14 October 2025
Abalos Therapeutics Publishes in Cell Reports Medicine Validating ABX-001's Potential to Overcome Cancer Immunotherapy Hurdles
09 October 2024
Abalos Therapeutics Appoints Gerben Moolhuizen as Chief Executive Officer
18 March 2024
Abalos selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)
18 October 2022
Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer
12 August 2022
Abalos Therapeutics---arenaviruses take on cancer
14 October 2021
Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million
05 February 2020
Abalos Therapeutics Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts
15 October 2019
Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
Events
Want to get in touch with the Abalos Therapeutics Team? Meet us at the following events:
February 10-12, 2026
IO360° Summit 2026
March 4-5, 2026
19th Annual European Life Sciences CEO Forum
March 15-18, 2026
Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations
Location: Quebec, Canada
Participant: Philipp A. Lang, Scientific Founder, Director of the Department of Molecular Medicine II, University Düsseldorf, Germany
April 15-19, 2026
AAI Conference Immunology 2026
Location: Boston, USA
Participant: Philipp A. Lang, Scientific Founder, Director of the Department of Molecular Medicine II, University Düsseldorf, Germany
April 17-22, 2026
AACR Annual Meeting 2026
Location: San Diego, USA
Participant: Philipp A. Lang, Scientific Founder, Director of the Department of Molecular Medicine II, University Düsseldorf, Germany
April 26-29, 2026
International Oncolytic Virus Conference
Location: Reykjavik, Iceland
Participant: Maria Honholt Christensen, Research Scientist
April 27-30, 2026
BioProcess International Europe Conference
Location: Vienna, Austria
Participants: Dethardt Mueller, CTO & Binod Prasad, Senior Principal Scientist
May 4-5, 2026
26th Bio€quity
June 7-10, 2026
29th ESACT Meeting
Location: Salzburg, Austria
Participant: Sinisa Petrik, Senior Scientist Bioprocess Development
June 22-25, 2026
BIO International Convention
June 23-24, 2026
International LIT Symposium
Location: Regensburg, Germany
Participant: Maria Honholt Christensen, Research Scientist